Peptides may be one part of that plan for some people
The BPC-157 peptide has three features that distinguish it in preclinical research: its natural gastric origin (making it uniquely stable in biological environments), its dual-pathway mechanism (VEGFR2 angiogenesis and NO modulation simultaneously), and its documented activity across nine distinct tissue systems
Combined use of both compounds is entirely unstudied in humans and carries unpredictable metabolic and cardiovascular risks
As a board-certified pain management physician specializing in regenerative medicine, I have seen how peptide therapy can transform outcomes for patients who have exhausted conventional options
This is why, despite the exciting research, I do not currently offer BPC-157 injections or oral peptide supplements in my clinical practice
Our team will work with you to determine the most appropriate dosing schedule and discuss any available discounts or package deals to best meet your health and financial needs
